InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Osman Ronald e. Officer active across 1 company, notably Inhibitor Therapeutics, Inc.. In total, 4 disclosures have been published. History available since 11 August 2023. The latest transaction was filed on 4 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
A declarant linked to Inhibitor Therapeutics, Inc. (XNAS), where he is listed as Director. The block shows 4 filings in total, and the 4 sampled filings, all of attribution nature, run from 2023-08-29 to 2026-08-04, with 0 in buys and 0 in sells.